Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe(Duke University), Eric B. Suhler(Oregon Health & Science University)
Cited by 646
Related Papers
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
|Ophthalmology|2012|1.7k
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
|Ophthalmology|2016|702
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
|Ophthalmology|2013|585
Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
|Ophthalmology|2013|325